当前位置: X-MOL 学术JAMA Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer and Response to Checkpoint Inhibition
JAMA Oncology ( IF 28.4 ) Pub Date : 2024-02-08 , DOI: 10.1001/jamaoncol.2023.6817
Peter D. Zang 1 , Neal S. Chawla 1 , Regina Barragan-Carrillo 1 , Alex Chehrazi-Raffle 1 , Abhishek Tripathi 1 , Sumanta K. Pal 1 , Tanya B. Dorff 1
Affiliation  

This single-center cohort study assesses the association of tumor mutational burden status in patients with metastatic castration-resistant prostate cancer and response to immune checkpoint inhibitor therapy.

中文翻译:

转移性去势抵抗性前列腺癌的肿瘤突变负担和对检查点抑制的反应

这项单中心队列研究评估了转移性去势抵抗性前列腺癌患者的肿瘤突变负荷状态与免疫检查点抑制剂治疗反应之间的关系。
更新日期:2024-02-08
down
wechat
bug